Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,534 | 211 | 97.7% |
| Education | $81.86 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $464.13 | 31 | $0 (2024) |
| Novo Nordisk Inc | $351.46 | 21 | $0 (2023) |
| Allergan, Inc. | $288.26 | 22 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $215.42 | 14 | $0 (2019) |
| PFIZER INC. | $210.51 | 16 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $210.24 | 15 | $0 (2022) |
| Amgen Inc. | $162.61 | 7 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $161.03 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $108.23 | 6 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $99.37 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $485.64 | 25 | Lilly USA, LLC ($151.61) |
| 2023 | $382.70 | 20 | Lilly USA, LLC ($140.59) |
| 2022 | $139.86 | 8 | Nestle HealthCare Nutrition Inc. ($62.51) |
| 2021 | $162.26 | 10 | PFIZER INC. ($35.71) |
| 2020 | $185.05 | 12 | Arbor Pharmaceuticals, Inc. ($46.94) |
| 2019 | $896.74 | 56 | Novo Nordisk Inc ($159.97) |
| 2018 | $856.01 | 53 | Allergan Inc. ($176.42) |
| 2017 | $508.03 | 29 | Merck Sharp & Dohme Corporation ($112.90) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $37.19 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $30.80 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DIABETES | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Cardio-renal | ||||||
| 07/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Biological | ||||||
| 04/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Diabetes | ||||||
| 03/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Inflammation | ||||||
| 01/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,443 | 2,147 | $291,435 | $140,152 |
| 2022 | 21 | 1,801 | 2,549 | $331,460 | $163,825 |
| 2021 | 24 | 1,819 | 2,607 | $308,060 | $165,842 |
| 2020 | 27 | 2,167 | 3,014 | $332,619 | $166,663 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 243 | 325 | $97,500 | $45,601 | 46.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 319 | $68,585 | $30,030 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $31,500 | $18,070 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 151 | 219 | $32,850 | $14,191 | 43.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 117 | $14,605 | $7,857 | 53.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 24 | 24 | $6,840 | $4,374 | 64.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 241 | 529 | $7,045 | $4,132 | 58.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 20 | 20 | $4,000 | $2,616 | 65.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 123 | 123 | $3,690 | $2,597 | 70.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 196 | 205 | $6,965 | $2,362 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 43 | $4,085 | $1,792 | 43.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,850 | $1,608 | 41.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 27 | 34 | $3,060 | $1,557 | 50.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 16 | $2,940 | $1,481 | 50.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 13 | $3,120 | $1,200 | 38.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $800.00 | $682.80 | 85.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 256 | 349 | $104,760 | $49,530 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 356 | $76,540 | $34,025 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 144 | 144 | $36,000 | $21,064 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 137 | 201 | $30,150 | $12,198 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 110 | $13,200 | $6,750 | 51.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 92 | 94 | $9,870 | $6,604 | 66.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 29 | 29 | $5,720 | $3,829 | 66.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 95 | 99 | $3,960 | $3,336 | 84.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,560 | $2,984 | 65.4% |
About Dr. Robert Comer, MD
Dr. Robert Comer, MD is a Internal Medicine healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134233158.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Comer, MD has received a total of $3,616 in payments from pharmaceutical and medical device companies, with $485.64 received in 2024. These payments were reported across 213 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,534).
As a Medicare-enrolled provider, Comer has provided services to 7,230 Medicare beneficiaries, totaling 10,317 services with total Medicare billing of $636,482. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Long Beach, CA
- Active Since 08/18/2006
- Last Updated 01/20/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134233158
Products in Payments
- Ozempic (Drug) $288.92
- MOUNJARO (Drug) $223.30
- ZENPEP (Drug) $209.98
- JANUVIA (Drug) $183.12
- XARELTO (Drug) $151.64
- JARDIANCE (Drug) $140.98
- LINZESS (Drug) $127.80
- CONTRAVE (Drug) $122.01
- Trintellix (Drug) $111.48
- Edarbi (Drug) $99.37
- LYRICA (Drug) $95.39
- Otezla (Drug) $95.21
- BASAGLAR (Drug) $93.83
- VOQUEZNA (Drug) $92.80
- IGT_D Peripheral (Device) $89.39
- Vascepa (Drug) $85.01
- ENTRESTO (Drug) $81.16
- AXIS (Biological) $73.51
- TRULICITY (Drug) $69.75
- INVOKANA (Drug) $58.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Long Beach
Jennifer Connelly, D.o, D.O
Internal Medicine — Payments: $275,877
Dr. Mark Lee, Md, MD
Internal Medicine — Payments: $142,649
Dr. Mark Leibowitz, M.d, M.D
Internal Medicine — Payments: $103,211
Dr. Steven Appleby, Md, MD
Internal Medicine — Payments: $101,644
Dr. Milan Sheth, Md, MD
Internal Medicine — Payments: $71,682
Katya Corado, M.d, M.D
Internal Medicine — Payments: $30,357